CLINICAL_TRIALS
research
· 2025-01-07
Clinical Trial Update: Exploring the Relationship Between L-dopa Responsiveness and Small Intestinal Microbiome in Parkinson's Disease
Summary
University of Calgary is conducting a clinical study to examine whether levodopa response in Parkinson's disease is linked to the small intestinal microbiome. T…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Calgary | Conditions: Parkinson Disease | Status: NOT_YET_RECRUITING